TGFB1 and neoplasm: Inhibition of either HIF-1α or TGF-β signaling in the tumor cells by shRNA knockdown or expression of a dominant-negative TβRII [6] decreased osteolytic lesion area and increased survival of mice with bone metastases compared to those bearing control cells.